This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Ferrer Internacional, S.a.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Berta Fernández Mollar: Innovator in Pharmaceutical Formulations
Introduction
Berta Fernández Mollar is a notable inventor based in Sant Cugat del Vallès, Spain. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative solid dosage forms. Her work focuses on enhancing the therapeutic efficacy of medications through advanced formulations.
Latest Patents
Berta holds a patent for her invention titled "Multilayer pharmaceutical or nutraceutical solid dosage forms comprising pyrimidine and/or purine derivatives and B vitamins." This patent describes a multilayer solid dosage form that includes at least one pyrimidine derivative, purine derivative, or any salt or solvate thereof, along with at least one B-group vitamin. The invention also outlines three methods for producing these multilayer forms and highlights their therapeutic uses, especially in the treatment and prevention of peripheral neuropathy. She has 1 patent to her name.
Career Highlights
Berta is associated with Ferrer Internacional, S.A., where she applies her expertise in pharmaceutical development. Her innovative approach has positioned her as a key player in the industry, contributing to advancements in nutraceutical and pharmaceutical formulations.
Collaborations
Berta has collaborated with notable colleagues, including Pablo Martín Sáiz and Javier Urbano Hurtado. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.
Conclusion
Berta Fernández Mollar exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions through her patent and collaborations continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
